2-((6-chloro-3-methyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)methyl)-4-Fluorobenzonitrile

1H-Imidazole-1-ethanamine, 4-amino-N-(2,2-dimethylpropyl)-beta,beta-dimethyl-

Pharmaceutical intermediate

1,1-Dimethylethyl N-((1S,3S)-3-((4-methoxy-3-(3-methoxypropoxy)phenyl)methyl)-4-methyl-1-((2S,4S)-tetrahydro-4-(1-methylethyl)-5-oxo-2-furanyl)pentyl)carbamate

Aliskiren intermediate

2-(Chloromethyl)-4-methoxy-3-methylpyridine--hydrogen chloride (1/1)

Pharmaceutical intermediate synthesis

2-(Chloromethyl)-4-methoxy-3,5-dimethylpyridine Hydrochloride

Pharmaceutical intermediate

2-((6-Chloro-3-methyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)methyl)benzonitrile

pharmaceutical intermediate

2-[(6-Chloro-3,4-dihydro-3-methyl-2,4-dioxo-1(2H)-pyrimidinyl)methyl]-benzonitrile-d3

pharmaceutical impurity reference standard

2-((6-Chloro-3-ethyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)methyl)benzonitrile

Alogliptin benzoate impurity intermediate

1-(2-Fluoro-6-(trifluoromethyl)benzyl)-5-iodo-6-methylpyrimidine-2,4(1H,3H)-dione

pharmaceutical intermediate